An observational study in Site Infection, sponsored by Assiut University. Not yet recruiting at 1 site in Egypt. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-03-17.
Sponsored by Assiut University · Observational
aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.
Cesarean Section is one of the most commonly performed obstetric surgical procedures worldwide. Despite its importance in reducing maternal and fetal complications, it is associated with several postoperative complications, the most important of which is Surgical Site Infection. Surgical site infection after cesarean section can lead to increased maternal morbidity, prolonged hospital stay, and higher healthcare costs. Therefore, evaluating the incidence of surgical site infection and assessing adherence to preventive measures are essential for improving the quality of obstetric care. This study aims to determine the incidence of surgical site infection after cesarean section and to assess compliance with infection prevention strategies.
Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
The study population will include all women undergoing Cesarean Section at El-Mabarra Health Insurance Hospital during the study period. Eligible participants will be followed for 30 days after delivery to detect the occurrence of Surgical Site Infection. Women who meet the inclusion criteria and agree to participate in the study will be enrolled consecutively until the required sample size is reached.
Exclusion Criteria:
Patients with immunocompromised conditions, such as:
Chronic corticosteroid therapy. Immunosuppressive treatment. Known HIV infection with severe immunosuppression .
incidence of surgical site infection after cesarean section
superficial or deep surgical site infection
Time frame: Baseline
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University